#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis acute Stargardt's disease Dementia with Lewy bodies Marginal zone lymphoma recurrent Pleomorphic liposarcoma Endometrial adenocarcinoma Guillain-Barre syndrome Breast angiosarcoma metastatic Angiosarcoma Lupus nephritis Fusarium infection Alveolar rhabdomyosarcoma Primary immunodeficiency syndrome Follicular lymphoma stage III Ewing's sarcoma metastatic More trials…

    Learn about Rare Diseases

    IgA nephropathy – Life with Disease Testicular leiomyosarcoma Haemophilia A with anti factor VIII – Diagnostics Langerhans cell sarcoma – Basic Information Angiosarcoma – Life with Disease Crigler-Najjar syndrome – Diagnostics Systemic sclerosis pulmonary – Diagnostics Mucopolysaccharidosis III – Life with Disease Myelodysplastic syndrome Retinoblastoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lithium Carbonate Tofersen Daratumumab Dexamethasone Sodium Phosphate Indacaterol Acetate Enlicitide Chloride Quinine Dihydrochloride Cisplatin Tramazoline Hydrochloride Damoctocog Alfa Pegol Quemliclustat Dfv890 GRNA1599 Sparsentan Thymalfasin Hydroxychloroquine Sulfate Anb032 Cinchocaine Hydrochloride Carbetocin GRNA-001 More therapies…

    Learn about Your Condition

    Tympanic membrane hyperaemia Neuroendocrine tumour Ichthyosis Colon cancer stage IV Chronic myeloid leukaemia Childhood asthma Periodontitis Elderly Vascular graft thrombosis Eye disorder Laryngeal cancer stage II Aicardi-Goutieres syndrome Lung transplant Open angle glaucoma Renal cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Ketamine and Esketamine on Brain Activity in Healthy Volunteers

    Recruiting

    1 1 1
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Ketamine Hydrochloride
    • Sodium Chloride
    Austria

  • Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Modified Vaccinia Ankara – Bavarian Nordic Live Virus
    Belgium France Ireland Sweden

  • Study Comparing High-Dose and Standard-Dose Inactivated Influenza Vaccines in Adults with Blood Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • INFLUENZA VIRUS A/DARWIN/9/2021 IVR-228 (H3N2)
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    Belgium

  • Study on How Bevacizumab Affects the Immune System in Patients with Glioblastoma Multiforme

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Bevacizumab
    Hungary

  • Study on the Impact of Cisplatin and Drug Combination on Speech and Cognition in Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Testis cancer
    • Head and neck cancer
    Investigated Drugs:
    • Bleomycin Sulfate Ph. Eur.
    • Mesna
    • Ifosfamide
    Finland

  • Study on Vitamin D3 (Colecalciferol) Supplementation in Young Adults and Seniors to Compare Effects and Develop Age-Specific Models

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    Czechia
Previous Page
1 … 185 186 187 188 189 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!